DVT/VTE
News
Pediatrics group stresses benefits of vitamin K shots for infants
Infants who do not receive vitamin K at birth are 81 times more likely to develop late-onset vitamin K deficiency bleeding, which occurs a week to...
From the Journals
Antithrombotic therapy not warranted in COVID-19 outpatients
In stable patients with COVID-19, use of aspirin or apixaban did not reduce the rate of the composite of all-cause mortality, thromboembolism, MI...
From the Journals
Study suggests no added risk of blood clots in COVID-19 outpatients
Conference Coverage
Antibody hierarchy may drive development of SLE vs. antiphospholipid syndrome
MADRID – Specific antiphospholipid antibodies have differing influences on the manifestations of two important autoimmune diseases.
Conference Coverage
Occurrence of pulmonary embolisms in hospitalized patients nearly doubled during 2004-2015
NEW ORLEANS – National Inpatient Sample data showed that during 2004-2015 hospitalized U.S. patients with a PE diagnosis jumped by 80%.
From the Journals
Algorithm ruled out PE, averts radiation exposure in pregnant women
Only one deep-vein thrombosis and no pulmonary embolism occurred in 3 months of follow-up in nearly 500 women.
Conference Coverage
Repeat VTE risk heightened in HIV patients
SEATTLE – Two studies detail the risk factors of first-time venous thromboembolism and heightened incidence of repeat VTE in patients with HIV.
Conference Coverage
Phase 3 data support apixaban for cancer-associated VTE
The rate of major bleeding was similar with apixaban and dalteparin.
Conference Coverage
Large cohort study IDs prognostic factors in thromboangiitis obliterans
CHICAGO – Ethnicity and limb infection are independent predictors of poor outcomes, including limb amputation, in TAO.
From the Journals
AVERT: Apixaban reduced thromboembolism risk in cancer patients
Cancer patients treated with apixaban had a significantly lower rate of venous thromboembolism but a higher risk of major bleeds than did those...